PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
29-Jul-2022 ViiV Healthcare presents positive five-year data at AIDS 2022, demonstrating the durability of fostemsavir in people living with HIV who are heavily treatment-experienced ViiV Healthcare
29-Jul-2022 Weekly Pharma & Life Sciences News Round-Up: 25th – 29th July PharmiWeb.Jobs
29-Jul-2022 MediClin AG: Consolidated sales for the first half of 2022 up 10% on the previous pandemic figure – no change in forecast MediClin AG
29-Jul-2022 ViiV Healthcare and the Medicines Patent Pool sign new voluntary licensing agreement to expand access to innovative long-acting HIV prevention medicine ViiV Healthcare
29-Jul-2022 NICE recommends Novartis Beovu® (brolucizumab) for thousands with sight loss due to diabetes Novartis
29-Jul-2022 Dante Genomics to Participate in a Panel Presentation at the Canaccord Genuity 42nd Annual Growth Conference Dante Genomics
29-Jul-2022 2022 Annual General Meeting Statement and Trading Update Mediclinic
29-Jul-2022 NeoPhore Enters Three Year Research Collaboration with World Leading Oncologist’s Lab at Major US Cancer Center NeoPhore
29-Jul-2022 Successful completion of Series A for Medtech-Startup PreciPoint PreciPoint Group GmbH
29-Jul-2022 Strong execution in Q2 drives full-year 2022 guidance upgrade and delivers rich R&D news flow in Immunology and Rare Disease Sanofi
29-Jul-2022 Velocity Clinical Research begins European expansion with German site acquisition Velocity Clinical Research
29-Jul-2022 PCI Pharma Services Announces Multi-Million Dollar Expansion to UK Manufacturing Facility to Meet Growing Demand for Global High Potent Manufacturing Services Supporting Oncology Treatments PCI Pharma Services
29-Jul-2022 Medacta Group SA reports 19.0% growth of half-year revenue Medacta Group SA
28-Jul-2022 MorphoSys AG: Invitation to MorphoSys’ Second Quarter and First Half Year 2022 Results Conference Call on August 4 , 2022 MorphoSys AG
28-Jul-2022 aap Implantate AG: Q2 weaker than expected and adjustment of guidance for the financial year 2022 due to increased macroeconomic uncertainties in H2 aap Implantate AG
28-Jul-2022 Biotest AG: Biotest increases EBITDA in first half-year by 52% to 8.8 million EUR Biotest AG
28-Jul-2022 Drägerwerk AG & Co. KGaA: Dräger expects significant recovery in business development in the second half of 2022 Drägerwerk AG & Co. KGaA
28-Jul-2022 Spexis provides business update Spexis AG
28-Jul-2022 Cosmo reports strong half-year 2022 financial results delivering record revenues and reaffirms 2022 full-year guidance Cosmo Pharmaceuticals N.V.
28-Jul-2022 Acer Therapeutics and Relief Therapeutics Announce ACER-001 IND Submission for the Treatment of Maple Syrup Urine Disease Relief Therapeutics Holding SA